$DYN 4 SEC Filings

Filed On	Filing
22 Oct 2026	Form 4: Kerr Douglas, Head of R&D and CMO Received 8,000 shares as a grant or award · Granted 12,000 Stock option (right to buy)
06 Oct 2026	Form 4: Posner Brian S, Director Bought 2,500 shares ($40K)
08 Sep 2026	Form 4: Friedl-Naderer Johanna, Chief Commercial Officer Sold 900 shares ($21.9K) · Sold 185 shares ($3.49K)
08 Sep 2026	Form 4: Kerr Douglas, Chief Medical Officer Sold 3,745 shares ($91.2K) · Sold 1,290 shares ($24.4K)
08 Sep 2026	Form 4: Cox John, Director Sold 5,658 shares ($107K)
17 Aug 2026	Form 4: Rhodes Jason P, Director Sold 426,412 shares ($11.2M) · Sold 2,160,516 shares ($54M)
17 Aug 2026	Form 4: Friedl-Naderer Johanna, Chief Commercial Officer Sold 226 shares ($5.94K)
17 Aug 2026	Form 4: Kerr Douglas, Chief Medical Officer Sold 1,556 shares ($40.9K)
17 Aug 2026	Form 4: Cox John, Director Sold 4,986 shares ($131K)
17 Aug 2026	Form 4: Lucera Erick, Chief Financial Officer Sold 1,797 shares ($47.2K)
29 Jul 2026	Form 4: Kersten Dirk, Director Sold 261,460 shares ($6.67M)
08 Jul 2026	Form 4: Rhodes Jason P, Director Sold 480,240 shares ($10.9M) · Sold 297,211 shares ($6.91M)
30 Jun 2026	Form 4: Rhodes Jason P, Director Sold 309,268 shares ($6.58M) · Sold 195,427 shares ($4.13M)
26 Jun 2026	Form 4: Lucera Erick, Chief Financial Officer Sold 2,362 shares ($48.1K)
26 Jun 2026	Form 4: Rhodes Jason P, Director Sold 147,760 shares ($3.12M) · Sold 95,900 shares ($2.02M) · Sold 24,100 shares ($509K)
24 Jun 2026	Form 4: Kersten Dirk, Director Sold 190,676 shares ($3.92M) · Sold 73,286 shares ($1.54M)
23 Jun 2026	Form 4: Greene Barry E, Director Granted 57,463 Stock option (right to buy)
22 Jun 2026	Form 4: Kersten Dirk, Director Sold 37,454 shares ($754K) · Sold 46,901 shares ($941K)
17 Jun 2026	Form 4: Kerr Douglas, Chief Medical Officer Sold 887 shares ($16.3K)
17 Jun 2026	Form 4: Friedl-Naderer Johanna, Chief Commercial Officer Sold 145 shares ($2.66K)

Comments